Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
74
datasets available to search
ShareScore release 0.9.0
Dataset results
74 results for “essential thrombocythemia”
Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera
ClinicalTrials.gov study NCT01243073. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Arterial Function and Atherosclerosis in Essential Thrombocythemia
ClinicalTrials.gov study NCT03828422. IPD Sharing: UNDECIDED. Countries: 0. Publications: 2.
Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia
ClinicalTrials.gov study NCT02407080. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia
ClinicalTrials.gov study NCT02611973. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofi
ClinicalTrials.gov study NCT04676529. IPD Sharing: NO. Countries: 4. Publications: 1.
Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
ClinicalTrials.gov study NCT00715247. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
ClinicalTrials.gov study NCT04285086. IPD Sharing: NO. Countries: 8. Publications: 2.
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
ClinicalTrials.gov study NCT02953704. IPD Sharing: UNDECIDED. Countries: 2. Publications: 3.
18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia
ClinicalTrials.gov study NCT03116542. IPD Sharing: NO. Countries: 1. Publications: 14.
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
ClinicalTrials.gov study NCT03165734. IPD Sharing: NO. Countries: 24. Publications: 1.
Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
ClinicalTrials.gov study NCT01998828. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibros
ClinicalTrials.gov study NCT02436135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00718159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/E
ClinicalTrials.gov study NCT01668173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2
ClinicalTrials.gov study NCT04081220. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis
ClinicalTrials.gov study NCT02087059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential
ClinicalTrials.gov study NCT02124746. IPD Sharing: NO. Countries: 5. Publications: 0.
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
ClinicalTrials.gov study NCT03123588. IPD Sharing: NO. Countries: 1. Publications: 0.
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
ClinicalTrials.gov study NCT02421354. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
ClinicalTrials.gov study NCT01369498. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.